Please turn JavaScript on

The Motley Fool

Subscribe to The Motley Fool’s news feed.

Click on “Follow” and decide if you want to get news from The Motley Fool via RSS, as email newsletter, via mobile or on your personal news page.

Subscription to The Motley Fool comes without risk as you can unsubscribe instantly at any time.

You can also filter the feed to your needs via topics and keywords so that you only receive the news from The Motley Fool which you are really interested in. Click on the blue “Filter” button below to get started.

Title: The Motley Fool

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  148.28 / day

Message History

Tesla (NASDAQ:TSLA), an electric vehicle (EV), autonomous driving software, and energy storage company, closed at $342.27, up 0.68%. Recent momentum and TD Cowen's “buy” reiteration helped shares, while investors are watching progress in robotics and autonomous driving.
Trading volume reached 45.1 million shares, coming in roughly 4.6% above its three-mo...


Read full story
Key Points

BigBear.ai focuses on high-stakes artificial intelligence and predictive analytics for the U.S. intelligence community and defense agencies.

Texas Instruments provides essential analog and embedded semiconductors to over 100,000 customers in industrial and automotive markets.

Which of these technology-focused plays is the better fit for your long-term po...


Read full story
Key Points

AppLovin currently demonstrates a visibly stronger revenue profile, consistently maintaining a massive financial footprint and larger baseline of total recognized sales when compared against SoundHound's smaller commercial operations.

Over the course of the last eight quarters, the two companies largely experienced consistently positive quarter-over-quarter re...


Read full story
Key Points

CrowdStrike maintains a dominant position in the cloud security market with its Falcon platform and over 88,000 customers.

IonQ is a high-growth pioneer in quantum computing that is rapidly scaling its revenue through major cloud partnerships and hardware acquisitions.

Which of these two specialized technology companies is the better fit for your growth ...


Read full story
Key Points

Vertex Pharmaceuticals appears likely to continue to dominate its core therapeutic area.

The company is slowly developing and launching medicines in other markets.


Read full story